Royal Lancaster Infirmary
Lancaster, United Kingdom
NCT Number: NCT03446092
The study will investigate whether a mindfulness course can help people with incurable cancer who are seen by oncologists in a particular National Health Service Hospital Trust in the United Kingdom.
Looking for future studies?
Notify MeIt can be hard to come to terms with living with a life limiting condition such as incurable cancer and individuals are at risk of experiencing high levels of psychological distress, which can often be overlooked when the focus is on managing physical symptoms.
Mindfulness-based interventions have been shown to be helpful in reducing distress for people with cancer generally. This pilot study will use an established mindfulness programme called mindfulness for health with people with cancer which is incurable to see if this type of intervention is acceptable and useful for this group of people.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A course of mindfulness using the mindfulness for health programme.
Time frame: Within 4 weeks of the end of the intervention
This will be a qualitative outcome, collected via semi-structured interview
Time frame: 3 months following completion of the intervention
This will be a qualitative outcome, collected via semi-structured interview
Time frame: Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Using the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.
Time frame: Collected before the intervention (up to 4 weeks before the intervention) and 3 months after the end of the intervention
Using the Depression, Anxiety and Stress (DASS21) scale we will measure the change post intervention score - pre intervention score. Each subscale (depression, anxiety and stress) ranges from 0-21, with higher scores indicating higher distress. A greater decrease in scores, would mean a greater improvement in symptoms.
Time frame: Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Using the Five Factor Mindfulness Questionnaire we will measure pre-post change scores.
Time frame: Collected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention
Using the Five Factor Mindfulness Questionnaire we will measure pre-post change scores
Time frame: Collected before the intervention (up to 4 weeks before the intervention) and within 4 weeks of the end of the intervention
Using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores
Time frame: Collected before the intervention (up to 4 weeks before the intervention) and 3 months following the intervention
Using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire we will measure pre-post change scores
Lancaster University
Other
A Pilot Investigation of a Mindfulness Course for People With Incurable Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT01445483
Brain Diseases, Brain Metastasis
Bethesda, Maryland, United States
View Trial DetailsNCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsNCT03556384
Brain Diseases, Cancer
La Jolla, California, United States
View Trial Details